UnitedHealth Group Inc. (NYSE:UNH) 

The valuation ratios exhibited varied trends over the observed period, spanning from March 31, 2022, to December 31, 2025. Generally, a pattern of decline in these ratios was evident through much of 2023, followed by increases in 2024, and then a mixed performance into early 2025.

Price to Earnings (P/E)

The Price to Earnings ratio demonstrated a decreasing trend from 27.29 in March 2022 to a low of 20.53 by December 2022. This decline continued into 2023, reaching a minimum of 10.73 in June 2023. A significant increase was then observed in 2024, peaking at 36.59 in June, before moderating to 22.20 by the end of 2025. This suggests fluctuating investor sentiment regarding earnings potential.

Price to Operating Profit (P/OP)

Similar to the P/E ratio, the Price to Operating Profit ratio generally decreased from 19.69 in March 2022 to 14.20 in December 2022. The downward trend persisted through the first half of 2023, reaching 7.43 in June 2023. A recovery began in late 2023 and continued into 2024, peaking at 16.11 in June 2024, and settling at 14.12 by December 2025. This movement mirrors the P/E ratio, indicating a relationship between perceived earnings and operating profitability.

Price to Sales (P/S)

The Price to Sales ratio showed a consistent decline from 1.61 in March 2022 to a low of 0.55 in June 2023. A modest recovery occurred in 2024, reaching 1.35 in June, but then decreased again to 0.60 by December 2025. This suggests a decreasing valuation relative to revenue generation, potentially reflecting concerns about sales growth or profitability margins.

Price to Book Value (P/BV)

The Price to Book Value ratio experienced a decline from 6.54 in March 2022 to 5.18 in December 2022. This downward trend continued through June 2023, reaching 2.41. A partial recovery was seen in 2024, peaking at 5.77 in June, before ending the period at 2.84 in December 2025. This indicates a changing perception of the company’s net asset value relative to its market price.

Overall, the observed ratios suggest a period of increased valuation volatility. The declines in 2022 and 2023 could be attributed to broader market conditions or company-specific factors impacting investor confidence. The subsequent increases in 2024 may reflect a reassessment of the company’s prospects, although the ratios did not fully return to their earlier levels. The fluctuations into 2025 suggest continued uncertainty.

The price-to-earnings (P/E) ratio exhibited fluctuating behavior over the observed period, spanning from March 31, 2022, to December 31, 2025. Initial values indicated relative stability, followed by a period of decline and subsequent volatility.

Initial Period (Mar 31, 2022 – Dec 31, 2022)

The P/E ratio began at 27.29 and demonstrated modest fluctuation, peaking at 27.70 in June 2022 before decreasing to 22.46 by the end of the year. This suggests a generally stable valuation, with a slight contraction towards year-end.

2023 Performance

Throughout 2023, the P/E ratio remained relatively contained, fluctuating between 20.53 and 23.45. The ratio showed little directional movement, indicating a period of valuation consolidation. The average P/E for 2023 was approximately 22.3, consistent with the end of 2022.

Significant Shifts (2024)

A notable increase in the P/E ratio occurred in the first half of 2024, rising from 30.38 in March to 36.59 in June. This increase was followed by a substantial decline to 29.75 by September and further to 16.05 by the end of the year. This period reflects significant investor sentiment shifts, potentially driven by changes in earnings expectations or broader market conditions.

Recent Trends (2025)

The P/E ratio continued to exhibit volatility in 2025. It began at 10.73 in March, increased to 17.59 in September, and concluded at 22.20 in December. This suggests a recovery in valuation, although the ratio remained below levels observed in the earlier part of 2024. The fluctuations throughout 2025 indicate ongoing uncertainty or reassessment of the company’s future earnings potential.

Relationship to Earnings

The observed P/E ratio movements are closely tied to changes in earnings per share (EPS). While EPS generally increased through September 2023, the subsequent decline in EPS in 2024 coincided with the significant increase in the P/E ratio, followed by a sharp decline in the P/E ratio as EPS remained relatively stable. This suggests that market expectations played a crucial role in the valuation shifts, particularly in 2024.

In summary, the P/E ratio demonstrated a complex pattern over the analyzed timeframe. While initial periods showed stability, the latter half of the period was characterized by substantial fluctuations, likely influenced by both earnings performance and evolving market sentiment.

The Price to Operating Profit (P/OP) ratio for the observed period demonstrates a generally decreasing trend, punctuated by periods of fluctuation. Initially, the ratio exhibited relative stability, followed by a notable decline and subsequent volatility. A detailed examination reveals specific patterns and shifts in valuation.

Initial Period (Mar 31, 2022 – Dec 31, 2022)

The P/OP ratio began at 19.69 and fluctuated within a narrow range, peaking at 19.96 in June 2022 before declining to 15.89 by December 2022. This initial decrease suggests a potential shift in investor sentiment or a relative increase in operating profitability compared to the share price.

Subsequent Decline and Stabilization (Mar 31, 2023 – Sep 30, 2023)

The ratio continued its downward trajectory, reaching a low of 14.20 in December 2023. A slight recovery was observed through September 2023, with the ratio reaching 15.63, indicating a possible temporary correction. However, the overall trend remained negative.

Significant Drop and Volatility (Mar 31, 2024 – Dec 31, 2025)

A substantial decrease in the P/OP ratio commenced in March 2024, falling from 14.49 to a low of 7.43 in June 2025. This period coincided with a significant decline in the share price. The ratio experienced considerable volatility, rising to 11.74 in September 2025 and then to 14.12 in December 2025, suggesting increased uncertainty and potential market reactions to company-specific or broader economic factors. The fluctuations during this period are more pronounced than those observed earlier.

The observed trend indicates that the market valuation, relative to operating profit, has decreased considerably over the analyzed timeframe. The most dramatic shift occurred between March 2024 and June 2025, suggesting a significant re-evaluation of the company’s prospects. The subsequent volatility indicates ongoing uncertainty surrounding the company’s future performance and investor expectations.

Relationship to Share Price and Operating Profit

The decline in the P/OP ratio appears to be driven by a combination of factors. While operating profit per share remained relatively stable for much of the period, the share price experienced a more substantial decline, particularly after March 2024. This suggests that the market’s perception of the company’s future earnings potential diminished, leading to a lower valuation multiple.

In conclusion, the P/OP ratio demonstrates a clear downward trend with increasing volatility in the latter part of the observed period. This suggests a changing investor sentiment and a potential re-evaluation of the company’s valuation based on its operating performance and future outlook.

The price-to-sales ratio exhibited a generally declining trend over the observed period, punctuated by some quarterly fluctuations. Initially, the ratio demonstrated relative stability, followed by a more pronounced decrease beginning in late 2022 and continuing through 2025.

Initial Period (Mar 31, 2022 – Dec 31, 2022)

The price-to-sales ratio began at 1.61 and fluctuated between 1.61 and 1.66 for the first three quarters. A noticeable decrease was observed in the final quarter of 2022, falling to 1.40. This suggests a potential shift in market valuation relative to sales during this period.

Declining Trend (Mar 31, 2023 – Dec 31, 2024)

From March 2023 through December 2024, the ratio continued its downward trajectory, decreasing from 1.37 to 1.08. While some quarterly variations existed, the overall trend remained consistently negative. This indicates increasing pressure on the stock price relative to the company’s sales performance.

Significant Decrease (Mar 31, 2025 – Dec 31, 2025)

The most substantial declines occurred in 2025. The ratio dropped from 0.88 in March to 0.55 in June, representing a significant contraction. A slight recovery to 0.72 in September was followed by a further decrease to 0.60 by the end of the year. This final period demonstrates a considerable devaluation of the stock in relation to sales.

Sales per Share Trend

Concurrently, sales per share consistently increased throughout the period, rising from 314.77 to 488.77. This upward trend in sales per share contrasts with the declining price-to-sales ratio, suggesting that the decrease in the ratio is primarily driven by changes in the share price rather than sales performance.

In summary, while sales per share demonstrated consistent growth, the price-to-sales ratio experienced a marked decline, particularly in the latter half of the observation period. This divergence suggests a weakening market valuation of the company’s stock relative to its sales revenue.

The price-to-book value (P/BV) ratio for the observed period demonstrates a fluctuating pattern, generally trending downward over the long term. Initial values indicate a P/BV around 6.5 to 7.0 in the first four quarters of the period. Subsequent quarters reveal a decline, punctuated by periods of relative stability and minor increases.

Initial Period (Mar 31, 2022 – Dec 31, 2022)

The P/BV ratio began at 6.54 and peaked at 6.94 before decreasing to 5.81. This initial period suggests a relatively stable valuation based on book value, with a slight increase followed by a moderate contraction.

Intermediate Period (Mar 31, 2023 – Dec 31, 2023)

The ratio fluctuated between 5.18 and 5.77 during this time. While exhibiting some volatility, the P/BV remained within a similar range as the end of the prior period, indicating a continued, though less pronounced, valuation pattern.

Recent Period (Mar 31, 2024 – Dec 31, 2025)

A more significant downward trend is observed, with the P/BV ratio declining from 5.38 to 2.84. This represents a substantial decrease in the market’s valuation of the company relative to its book value. The lowest point in the observed period, 2.41, occurred in June 2025, followed by a slight recovery to 2.84 by the end of 2025.

The book value per share (BVPS) consistently increased throughout the period, rising from 77.56 to 103.68. This upward trend in BVPS occurred concurrently with the overall decline in the P/BV ratio, suggesting that the decrease in the P/BV ratio is not attributable to a decline in book value, but rather to a more significant decrease in the share price.

Share Price Impact

The share price experienced a considerable decline, particularly in the latter half of the observed period. Starting at 507.62, it decreased to 294.93 by December 31, 2025. This decline in share price is the primary driver of the decreasing P/BV ratio, as the numerator of the ratio decreased while the denominator increased.

Ratio Interpretation

The decreasing P/BV ratio may indicate that the market is becoming less optimistic about the company’s future earnings potential relative to its net asset value. Alternatively, it could suggest the market perceives the book value as an overstatement of the company’s true worth. A P/BV ratio below 3.0, as seen in the most recent observations, is generally considered low and may signal undervaluation, though further investigation is warranted.